Chromatin Remodeling Protein MORC2 Promotes Breast Cancer Invasion and Metastasis Through a PRD Domain-mediated Interaction with CTNND1

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Dec 13

PMID 29228664

Citations 24

Authors

Xiao-Hong Liao

Ye Zhang

Wen-Jie Dong

Zhi-Min Shao

Da-Qiang Li

Affiliations

Soon will be listed here.

Abstract

MORC family CW-type zinc finger 2 (MORC2) is a newly identified chromatin remodeling protein with emerging roles in the regulation of DNA damage response and gene transcription, but its mechanistic role in breast cancer development and progression remains unexplored. Here, we show that MORC2 promoted breast cancer invasion and metastasis and these effects depended on a proline-rich domain (PRD) within its carboxy-terminal region spanning residues 601-734. Induced expression of wild-type MORC2 did not significantly affect cell proliferation and cell-cycle progression, but promoted breast cancer cell migration and invasion and metastatic lung colonization . The PRD domain was dispensable for the protein stability and subcellular localization of MORC2, but depletion of the PRD domain substantially suppressed MORC2-mediated migration, invasion, and metastasis. Proteomic and biochemical analyses further demonstrated that wild-type MORC2, but not PRD deletion mutant, interacted with catenin delta 1 (CTNND1), a cadherin-associated protein that participates in tumor invasion and metastasis. Moreover, knockdown of endogenous CTNND1 by short hairpin RNAs suppressed the migratory and invasive potential of MORC2-expressing cells. Taken together, these results suggest that MORC2 promotes breast cancer invasion and metastasis through its PRD domain-mediated interaction with CTNND1.

Citing Articles

Emerging roles of the chromatin remodeler MORC2 in cancer metabolism.

Mohapatra B, Pakala S Med Oncol. 2024; 41(9):221.

PMID: 39117768 DOI: 10.1007/s12032-024-02464-9.

Novel Insights into the Role of Chromatin Remodeler MORC2 in Cancer.

Chutani N, Ragula S, Syed K, Pakala S Biomolecules. 2023; 13(10).

PMID: 37892209 PMC: 10605154. DOI: 10.3390/biom13101527.

High Expression of MORC2 is Associated with Poor Clinical Outcomes and Immune Infiltrates in Colon Adenocarcinoma.

Zhao P, Ning J, Huang J, Wei B, Wang Z, Huang X Int J Gen Med. 2023; 16:4595-4615.

PMID: 37850194 PMC: 10577261. DOI: 10.2147/IJGM.S420715.

Oncogenic MORC2 in cancer development and beyond.

Zhang S, Guo A, Wang H, Liu J, Dong C, Ren J Genes Dis. 2023; 11(2):861-873.

PMID: 37692502 PMC: 10491978. DOI: 10.1016/j.gendis.2023.05.010.

Towards Understanding the Key Signature Pathways Associated from Differentially Expressed Gene Analysis in an Indian Prostate Cancer Cohort.

Shukla N, Kour B, Sharma D, Vijayvargiya M, Sadasukhi T, Medicherla K Diseases. 2023; 11(2).

PMID: 37218885 PMC: 10204445. DOI: 10.3390/diseases11020072.

References

Jiang T, Qiu Y . Interaction between Src and a C-terminal proline-rich motif of Akt is required for Akt activation. J Biol Chem. 2003; 278(18):15789-93. DOI: 10.1074/jbc.M212525200. View

Tripathi A, King C, de la Morenas A, Perry V, Burke B, Antoine G . Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients. Int J Cancer. 2007; 122(7):1557-66. DOI: 10.1002/ijc.23267. View

Vleminckx K, Vakaet Jr L, Mareel M, Fiers W, VAN Roy F . Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 1991; 66(1):107-19. DOI: 10.1016/0092-8674(91)90143-m. View

Luga V, Zhang L, Viloria-Petit A, Ogunjimi A, Inanlou M, Chiu E . Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell. 2012; 151(7):1542-56. DOI: 10.1016/j.cell.2012.11.024. View

Wildenberg G, Dohn M, Carnahan R, Davis M, Lobdell N, Settleman J . p120-catenin and p190RhoGAP regulate cell-cell adhesion by coordinating antagonism between Rac and Rho. Cell. 2006; 127(5):1027-39. DOI: 10.1016/j.cell.2006.09.046. View

Campbell H, Mehta R, Neumann A, Rubio C, Baird M, Slatter T . Activation of p53 following ionizing radiation, but not other stressors, is dependent on the proline-rich domain (PRD). Oncogene. 2012; 32(7):827-36. DOI: 10.1038/onc.2012.102. View

Daniel J . Dancing in and out of the nucleus: p120(ctn) and the transcription factor Kaiso. Biochim Biophys Acta. 2006; 1773(1):59-68. DOI: 10.1016/j.bbamcr.2006.08.052. View

Venot C, Maratrat M, Dureuil C, Conseiller E, Bracco L, Debussche L . The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. EMBO J. 1998; 17(16):4668-79. PMC: 1170796. DOI: 10.1093/emboj/17.16.4668. View

Edwards S, Hananeia L, Eccles M, Zhang Y, Braithwaite A . The proline-rich region of mouse p53 influences transactivation and apoptosis but is largely dispensable for these functions. Oncogene. 2003; 22(29):4517-23. DOI: 10.1038/sj.onc.1206726. View

10.

Kelly K, Spring C, Otchere A, Daniel J . NLS-dependent nuclear localization of p120ctn is necessary to relieve Kaiso-mediated transcriptional repression. J Cell Sci. 2004; 117(Pt 13):2675-86. DOI: 10.1242/jcs.01101. View

11.

Li D, Nair S, Kumar R . The MORC family: new epigenetic regulators of transcription and DNA damage response. Epigenetics. 2013; 8(7):685-93. PMC: 3781187. DOI: 10.4161/epi.24976. View

12.

Li D, Pakala S, Reddy S, Ohshiro K, Zhang J, Wang L . Bidirectional autoregulatory mechanism of metastasis-associated protein 1-alternative reading frame pathway in oncogenesis. Proc Natl Acad Sci U S A. 2011; 108(21):8791-6. PMC: 3102345. DOI: 10.1073/pnas.1018389108. View

13.

Yoon H, Chan D, Reynolds A, Qin J, Wong J . N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol Cell. 2003; 12(3):723-34. DOI: 10.1016/j.molcel.2003.08.008. View

14.

Chen L, Kuo W, Tsai M, Chen P, Hsiao C, Chuang E . Identification of prognostic genes for recurrent risk prediction in triple negative breast cancer patients in Taiwan. PLoS One. 2011; 6(11):e28222. PMC: 3226667. DOI: 10.1371/journal.pone.0028222. View

15.

Toledo F, Krummel K, Lee C, Liu C, Rodewald L, Tang M . A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network. Cancer Cell. 2006; 9(4):273-85. DOI: 10.1016/j.ccr.2006.03.014. View

16.

Siegel R, Miller K, Jemal A . Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67(1):7-30. DOI: 10.3322/caac.21387. View

17.

Noren N, Liu B, Burridge K, Kreft B . p120 catenin regulates the actin cytoskeleton via Rho family GTPases. J Cell Biol. 2000; 150(3):567-80. PMC: 2175185. DOI: 10.1083/jcb.150.3.567. View

18.

Ishiyama N, Lee S, Liu S, Li G, Smith M, Reichardt L . Dynamic and static interactions between p120 catenin and E-cadherin regulate the stability of cell-cell adhesion. Cell. 2010; 141(1):117-28. DOI: 10.1016/j.cell.2010.01.017. View

19.

Dumaz N, Milne D, Jardine L, Meek D . Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover. Biochem J. 2001; 359(Pt 2):459-64. PMC: 1222167. DOI: 10.1042/0264-6021:3590459. View

20.

Roczniak-Ferguson A, Reynolds A . Regulation of p120-catenin nucleocytoplasmic shuttling activity. J Cell Sci. 2003; 116(Pt 20):4201-12. DOI: 10.1242/jcs.00724. View